Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-042396

Chief Financial Officer sold 10,000 shares at an average $12.54 ($125,364)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BLOCH KATHLEEN P. Chief Financial Officer 2018-08-03 Option exercise +10,000 $2.88 $28,750 260,004 D
BLOCH KATHLEEN P. Chief Financial Officer 2018-08-03 Sale −200 $12.85 $2,570 259,804 D
BLOCH KATHLEEN P. Chief Financial Officer 2018-08-03 Sale −6,200 $12.75 $79,050 253,604 D
BLOCH KATHLEEN P. Chief Financial Officer 2018-08-03 Sale −3,600 $12.15 $43,744 250,004 D
Derivatives
BLOCH KATHLEEN P. Chief Financial Officer 2018-08-03 Option exercise · Stock Option (Right to Buy) −10,000 10,000 D
Open-market sales · 10,000 sh · avg $12.54 · $125,364
Loading xslF345X03/tv500351_4.xml…